{"id":"https://openalex.org/W2000546905","doi":"https://doi.org/10.1016/s0924-9338(99)80714-7","title":"A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients","display_name":"A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients","alternate_titles":[],"publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W2000546905","doi":"https://doi.org/10.1016/s0924-9338(99)80714-7","mag":"2000546905","pmid":"https://pubmed.ncbi.nlm.nih.gov/10572324"},"language":"en","primary_location":{"id":"doi:10.1016/s0924-9338(99)80714-7","doi":"https://doi.org/10.1016/s0924-9338(99)80714-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-9338(99)80714-7","pdf_url":null,"source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000546905"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110144916","display_name":"D. Sechter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136727","display_name":"H\u00f4pital Saint-Jacques","ror":"https://ror.org/03n6qxm88","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978","https://openalex.org/I4210136727"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Sechter","raw_affiliation_strings":["Department of Psychiatry, CHU Saint-Jacques Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, CHU Saint-Jacques Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210136727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056932936","display_name":"Sylvie Troy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118061","display_name":"Pfizer (France)","ror":"https://ror.org/02c9yny10","country_code":"FR","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210118061"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Troy","raw_affiliation_strings":["Pfizer France Orsay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer France Orsay, France","institution_ids":["https://openalex.org/I4210118061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021753702","display_name":"S. Paternetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Paternetti","raw_affiliation_strings":["Inserm","Inserm; H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Inserm; H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210121705"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037464911","display_name":"Patrice Boyer","orcid":"https://orcid.org/0000-0001-8405-2155","observed_orcids":["https://orcid.org/0000-0001-8405-2155"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Boyer","raw_affiliation_strings":["CNRS, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210121705"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":1.0735,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.77046735,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"14","issue":"1","first_page":"41","last_page":"48"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9639999866485596},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8339999914169312},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.6520000100135803},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7300000190734863},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6859999895095825},{"id":"https://openalex.org/keywords/sleep-quality","display_name":"sleep quality","score":0.5419999957084656},{"id":"https://openalex.org/keywords/insomnia","display_name":"insomnia","score":0.5699999928474426},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.578000009059906},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9589999914169312},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.8230000138282776},{"id":"https://openalex.org/keywords/continuation-therapy","display_name":"continuation treatment","score":0.5849999785423279},{"id":"https://openalex.org/keywords/treatment-withdrawal","display_name":"treatment withdrawal","score":0.49000000953674316},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.6439999938011169},{"id":"https://openalex.org/keywords/somatic-symptoms","display_name":"somatic symptoms","score":0.5590000152587891},{"id":"https://openalex.org/keywords/agitation","display_name":"agitation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.94120192527771},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9335994720458984},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.8728111982345581},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5115767121315002},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5015208721160889},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47210589051246643},{"id":"https://openalex.org/C2781210005","wikidata":"https://www.wikidata.org/wiki/Q6738337","display_name":"Major depressive episode","level":3,"score":0.4580160677433014},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.4329114258289337},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.4240069091320038},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4151104688644409},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.40615954995155334},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36286887526512146},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.31396612524986267},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.28699791431427},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.1291012167930603},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.05013704299926758},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0924-9338(99)80714-7","doi":"https://doi.org/10.1016/s0924-9338(99)80714-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-9338(99)80714-7","pdf_url":null,"source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},{"id":"pmid:10572324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10572324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European psychiatry : the journal of the Association of European Psychiatrists","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W2071142","https://openalex.org/W103022166","https://openalex.org/W1814905825","https://openalex.org/W1946386597","https://openalex.org/W1997857340","https://openalex.org/W2003059806","https://openalex.org/W2005021105","https://openalex.org/W2010759906","https://openalex.org/W2032110109","https://openalex.org/W2032884131","https://openalex.org/W2042926123","https://openalex.org/W2050715406","https://openalex.org/W2062858990","https://openalex.org/W2082043522","https://openalex.org/W2089930737","https://openalex.org/W2105787852","https://openalex.org/W2137595593","https://openalex.org/W2166281097","https://openalex.org/W4233714330","https://openalex.org/W4248498496","https://openalex.org/W4249548153"],"related_works":["https://openalex.org/W2066482919","https://openalex.org/W1997857340","https://openalex.org/W2010759906","https://openalex.org/W2042926123","https://openalex.org/W1814905825","https://openalex.org/W2066145256","https://openalex.org/W3025195889","https://openalex.org/W2030799847","https://openalex.org/W7134885976","https://openalex.org/W7217899518"],"abstract_inverted_index":{"Depression":[0],"is":[1,34],"associated":[2,318],"with":[3,190,266,319,349],"considerable":[4],"morbidity":[5],"and":[6,41,99,148,158,166,210,216,260,305,329,336,340,344],"mortality.":[7],"As":[8],"depressive":[9,111],"disorders":[10],"carry":[11],"a":[12,23,239],"high":[13],"risk":[14],"of":[15,22,29,35,52,85,97,150,176,205,254,262,271,283],"relapse,":[16],"treatment":[17,203],"strategies":[18],"include":[19],"the":[20,30,48,53,60,65,81,183,187,193,201,252,272,324],"use":[21],"6-month":[24],"continuation":[25],"period":[26],"after":[27],"resolution":[28],"acute":[31],"episode.":[32],"Tolerability":[33],"major":[36,110],"importance":[37],"when":[38],"determining":[39],"compliance":[40],"outcome":[42],"during":[43],"long-term":[44],"therapy.":[45,73],"Due":[46],"to":[47,116,173,226,334],"superior":[49,321],"tolerability":[50],"profile":[51],"selective":[54],"serotonin":[55],"reuptake":[56],"inhibitors":[57],"(SSRIs)":[58],"over":[59,242],"older":[61],"tricyclic":[62],"antidepressants":[63],"(TCAs),":[64],"former":[66],"may":[67,90],"be":[68],"more":[69],"suitable":[70],"for":[71,109,131,135,200,287],"extended":[72],"Comparative":[74],"studies":[75],"have":[76],"not":[77],"shown":[78],"differences":[79,274,280,352],"between":[80,353],"SSRIs":[82],"in":[83,104,182,192,221,257,281],"terms":[84],"efficacy,":[86],"but":[87],"side-effect":[88],"profiles":[89],"vary.":[91],"A":[92],"multicenter,":[93],"double-blind,":[94],"comparative":[95],"study":[96,156,188,234],"sertraline":[98,118,184,208,267,284,316,343],"fluoxetine":[100,125,194,213,345],"was":[101,264,317],"carried":[102],"out":[103],"outpatients":[105],"fulfilling":[106],"DSM-III-R":[107],"criteria":[108],"disorder.":[112],"Patients":[113],"were":[114,153,171,198,219,285,346],"randomised":[115],"receive":[117],"(50-150":[119],"mg,":[120,127],"n":[121,128],"=":[122,129,297,303,312],"118)":[123],"or":[124],"(20-60":[126],"120)":[130],"24":[132],"weeks.":[133],"Assessments":[134],"depression":[136],"(HAM-D,":[137],"HAD,":[138],"CGI-I,":[139],"CGI-S),":[140],"anxiety":[141],"(Covi),":[142],"sleep":[143,335],"(Leeds":[144],"Sleep":[145,326],"Evaluation":[146,327],"scale)":[147],"quality":[149,261],"life":[151,263],"(SIP)":[152],"made":[154],"at":[155,159],"entry":[157],"weeks":[160],"2,":[161],"4,":[162],"8,":[163],"12,":[164],"18":[165],"24.":[167],"All":[168],"adverse":[169],"events":[170],"recorded":[172],"allow":[174],"evaluation":[175],"tolerability.":[177],"In":[178,314],"total,":[179],"88":[180],"patients":[181,209,218],"group":[185],"completed":[186],"compared":[189],"79":[191],"group.":[195],"Side":[196],"effects":[197],"responsible":[199],"premature":[202],"withdrawal":[204],"seven":[206],"(6%)":[207],"12":[211],"(10%)":[212],"patients.":[214],"Two-hundred":[215],"thirty-four":[217],"included":[220],"an":[222],"ITT":[223],"analysis":[224],"up":[225],"last":[227],"visit":[228],"(116":[229],"sertraline,":[230],"118":[231],"fluoxetine).":[232],"At":[233],"endpoint,":[235],"both":[236],"treatments":[237],"produced":[238],"significant":[240,279,351],"improvement":[241],"baseline":[243],"on":[244,323,330],"all":[245],"efficacy":[246],"variables":[247],"(P":[248,296,302,311],"<":[249],"0.001).":[250],"Although":[251],"magnitude":[253],"global":[255],"changes":[256],"depression,":[258],"anxiety,":[259],"larger":[265],"than":[268],"fluoxetine,":[269],"none":[270],"between-group":[273],"reached":[275],"statistical":[276],"significance.":[277],"However,":[278],"favour":[282],"observed":[286],"individual":[288],"HAM-D":[289],"items":[290,332],"including":[291],"item":[292,299,306],"4":[293],"(insomnia":[294],"onset)":[295],"0.04),":[298],"9":[300],"(agitation)":[301],"0.02),":[304],"13":[307],"(general":[308],"somatic":[309],"symptoms)":[310],"0.008).":[313],"addition,":[315],"significantly":[320],"performance":[322],"Leeds":[325],"scale":[328],"SIP":[331],"relating":[333],"rest,":[337],"emotional":[338],"behaviour":[339],"ambulation.":[341],"Both":[342],"well":[347],"tolerated":[348],"no":[350],"treatments.":[354]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000546905","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
